NCT05243355 2022-02-17Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLCQilu Hospital of Shandong UniversityPhase 2 Unknown46 enrolled
NCT03319316 2022-01-10SOLUTIONEuropean Organisation for Research and Treatment of Cancer - EORTCPhase 2 Withdrawn